skip to main content

H.R. 2281 (116th): Easy MAT for Opioid Addiction Act

The text of the bill below is as of Nov 13, 2020 (Preprint (Suspension)).

G:\M\16\SUSPENSION\H2281_SUS.XMLXXXXXXXXXXXXXXX11/16/2020 11:49XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 781012|1 [Discussion Draft] Suspend the Rules and Pass the Bill, H.R. 2281, With an Amendment (The amendment strikes all after the enacting clause and inserts a new text) XXXXXX (Original Signature of Member) [DISCUSSION DRAFT]



2d Session

H. R. 2281


April 10, 2019

introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


To direct the Attorney General to amend certain regulations so that practitioners may administer not more than 3 days’ medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.


Short title

This Act may be cited as the Easy Medication Access and Treatment for Opioid Addiction Act or the Easy MAT for Opioid Addiction Act.


Dispensation of narcotic drugs for the purpose of relieving acute withdrawal symptoms from opioid use disorder

Not later than 180 days after the date of enactment of this Act, the Attorney General shall revise section 1306.07(b) of title 21, Code of Federal Regulations, so that practitioners, in accordance with applicable State, Federal, or local laws relating to controlled substances, are allowed to dispense not more than a three-day supply of narcotic drugs to one person or for one person’s use at one time for the purpose of initiating maintenance treatment or detoxification treatment (or both).


Determination of budgetary effects

The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage.